Skip to Main Content

Paper Details

A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.
PLoS One
40
2016
Author NameAffiliation
Timothy S PardeeWake Forest School of Medicine
  • 1 - 1

Datasets

Release 1.2